http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-72881-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-10
filingDate 1998-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2005-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-72881-C2
titleOfInvention Translated By Plaj THIENOPYRIMIDINE AND THIENOPYRIMIDINE DERIVATIVES AS ANTI-CANCER
abstract In accordance with this invention, there are provided compounds of formulas (1) or (2) and their pharmaceutically acceptable salts or hydrates, in which X1, R1, R2 and R11 are defined, in accordance with the invention, a pharmaceutical composition is provided, which contains the proposed compounds of formulas (1 ) or (2), and a method of treating hyperproliferative disorders in mammals by administering compounds of formula (1) or (2). 2
priorityDate 1997-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412833013
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12603004

Total number of triples: 22.